Historical control data of neoplatic lesions in transgenic CBYB6F1-Tg(HRAS)2Jic (Tg.rasH2) mice

被引:0
|
作者
Paranjpe, Madhav [1 ]
Elbekai, Reem [1 ]
机构
[1] BioReliance, Rockville, MD USA
关键词
D O I
10.1016/j.toxlet.2013.05.488
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
引用
收藏
页码:S207 / S207
页数:1
相关论文
共 28 条
  • [1] Historical Control Data of Spontaneous Tumors in Transgenic CByB6F1-Tg(HRAS)2Jic (Tg.rasH2) Mice
    Paranjpe, Madhav G.
    Elbekaei, Reem H.
    Shah, Sudhir A.
    Hickman, Michelle
    Wenk, Martin L.
    Zahalka, Eias A.
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2013, 32 (01) : 48 - 57
  • [2] Historical control database of non-neoplastic lesions in transgenic CBYB6F1-Tg(HRAS)2Jic (Tg.rasH2) mice
    Elbekai, Reem
    Paranjpe, Madhav
    [J]. TOXICOLOGY LETTERS, 2013, 221 : S207 - S207
  • [3] Incidence of Spontaneous Non-Neoplastic Lesions in Transgenic CBYB6F1-Tg(HRAS)2Jic Mice
    Paranjpe, Madhav G.
    Shah, Sudhir A.
    Denton, Melissa D.
    Elbekai, Reem H.
    [J]. TOXICOLOGIC PATHOLOGY, 2013, 41 (08) : 1137 - 1145
  • [4] Comparison of the Class Effects of Antisense Oligonucleotides in CByB6F1-Tg(HRAS)2Jic and CD-1 Mice
    Kim, Tae-Won
    Papagiannis, Chris N.
    Zwick, Laura S.
    Engelhardt, Jeffery A.
    Hoffmaster, Christine M.
    Post, Noah M.
    Matson, John E.
    Hsiao, Jill A.
    Burel, Sebastien A.
    Henry, Scott P.
    [J]. TOXICOLOGIC PATHOLOGY, 2019, 47 (01) : 82 - 92
  • [5] A 26-Week Carcinogenicity Study with the Novel Glucagon Analog Dasiglucagon in CByB6F1-Tg(HRAS)2Jic Mice
    Elander, Mikael
    Froud, Adam
    [J]. DIABETES, 2021, 70
  • [6] CB6F1-Tg(HRAS)Nifdc小鼠与CByB6F1-Tg(HRAS)2Jic小鼠的脏器及血液生理指标测定与比较分析
    刘甦苏
    魏杰
    王辰飞
    岳秉飞
    范昌发
    [J]. 实验动物科学, 2021, 38 (03) : 23 - 28
  • [7] Tg.rasH2 Mice and not CByB6F1 Mice Should Be Used for 28-Day Dose Range Finding Studies Prior to 26-Week Tg.rasH2 Carcinogenicity Studies
    Paranjpe, Madhav G.
    Belich, Jessica
    Vidmar, Tom J.
    Elbekai, Reem H.
    McKeon, Marie
    Brown, Caren
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2017, 36 (04) : 287 - 292
  • [8] Assessment of the Carcinogenic Potential of Pretomanid in Transgenic Tg.rasH2 Mice
    Ambroso, Jeffrey L.
    Dillberger, John
    Bruning-Barry, Rebecca
    Yang, Tian
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2022, 41 (05) : 367 - 379
  • [9] Exudative inflammatory lesions in the nasal cavity in 28-day dose range finding studies in CByB6F1 mice and in 26-week carcinogenicity studies in Tg.rasH2 mice
    McKeon, Marie
    Elbekai, Reem H.
    Paranjpe, Mahdav
    Bruning, David
    [J]. TOXICOLOGY LETTERS, 2014, 229 : S151 - S151
  • [10] Approaches for Reducing the Number of Animals Used for 26-Week Alternate Carcinogenicity Studies in Transgenic Mice (Tg.rasH2)
    Shah, Sudhir A.
    Paranjpe, Madhav G.
    Wenk, Martin. L.
    Zahalka, Eias A.
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2011, 30 (01) : 110 - 110